505 related articles for article (PubMed ID: 26046540)
1. Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis.
Chen Y; Yan H; Song Z; Chen F; Wang H; Niu J; Shi X; Zhang D; Zhang N; Zhai Z; Zhong B; Cheng L; Qian T; Hao F
PLoS One; 2015; 10(6):e0127957. PubMed ID: 26046540
[TBL] [Abstract][Full Text] [Related]
2. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.
Ippagunta SK; Gangwar R; Finkelstein D; Vogel P; Pelletier S; Gingras S; Redecke V; Häcker H
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6162-E6171. PubMed ID: 27671649
[TBL] [Abstract][Full Text] [Related]
3. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway.
Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S
Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970
[TBL] [Abstract][Full Text] [Related]
4. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
[TBL] [Abstract][Full Text] [Related]
5. C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes.
Chen C; Wu N; Duan Q; Yang H; Wang X; Yang P; Zhang M; Liu J; Liu Z; Shao Y; Zheng Y
Sci Rep; 2018 Jun; 8(1):8590. PubMed ID: 29872130
[TBL] [Abstract][Full Text] [Related]
6. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
[TBL] [Abstract][Full Text] [Related]
7. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
9. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
10. Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.
Li C; Xiao L; Jia J; Li F; Wang X; Duan Q; Jing H; Yang P; Chen C; Wang Q; Liu J; Shao Y; Wang N; Zheng Y
J Invest Dermatol; 2019 Jan; 139(1):71-80. PubMed ID: 30009832
[TBL] [Abstract][Full Text] [Related]
11. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
Xiang S; Wu X; Xiang Y
Skin Pharmacol Physiol; 2022; 35(6):328-342. PubMed ID: 35960313
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
13. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
14. Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway.
Di T; Zhai C; Zhao J; Wang Y; Chen Z; Li P
Int Immunopharmacol; 2021 Oct; 99():107900. PubMed ID: 34233233
[TBL] [Abstract][Full Text] [Related]
15. CCN1, a Pro-Inflammatory Factor, Aggravates Psoriasis Skin Lesions by Promoting Keratinocyte Activation.
Sun Y; Zhang J; Zhou Z; Wu P; Huo R; Wang B; Shen Z; Li H; Zhai T; Shen B; Chen X; Li N
J Invest Dermatol; 2015 Nov; 135(11):2666-2675. PubMed ID: 26099024
[TBL] [Abstract][Full Text] [Related]
16. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
17. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
18. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]